Michael Liontos Challenges Selective Evidence in KEYLYNK-001 Ovarian Cancer Trial - Oncodaily
Michael Liontos Challenges Selective Evidence in KEYLYNK-001 Ovarian Cancer Trial Oncodaily
Ovarian Cancer News
Dana-Farber Expert Explains Rina-S Data in Platinum-Resistant Ovarian Cancer - Cure Today
Dana-Farber Expert Explains Rina-S Data in Platinum-Resistant Ovarian Cancer Cure Today
Eldorado woman with breast, ovarian cancer dedicated to prevention work - Santa Fe New Mexican
Eldorado woman with breast, ovarian cancer dedicated to prevention work Santa Fe New Mexican
Why doctors are urging women to redo early genetic tests for cancer risks - The Washington Post
Why doctors are urging women to redo early genetic tests for cancer risks The Washington Post
PMVP Stock Rises 19% in 3 Months: Here's What You Need to Know - TradingView
PMVP Stock Rises 19% in 3 Months: Here's What You Need to Know TradingView
Verastem Explores Avmapki Fakzynja Activity Outside of KRAS-Mutant Ovarian Cancer - GenomeWeb
Verastem Explores Avmapki Fakzynja Activity Outside of KRAS-Mutant Ovarian Cancer GenomeWeb
Breast and ovarian cancer survivor shares her story - KARK
Breast and ovarian cancer survivor shares her story KARK
“I get to live my life”: Nebraska woman joins ovarian cancer risk-reduction trial - University of Nebraska Medical Center
“I get to live my life”: Nebraska woman joins ovarian cancer risk-reduction trial University of Nebraska Medical Center
How New Science is Reshaping Ovarian Cancer Treatment and Care - American Association for Cancer Research
How New Science is Reshaping Ovarian Cancer Treatment and Care American Association for Cancer Research
Ovarian Cancer’s Hidden Weakness: An Arginine Gateway on the Cell Surface - Bioengineer.org
Ovarian Cancer’s Hidden Weakness: An Arginine Gateway on the Cell Surface Bioengineer.org
How new findings on ovarian cancer origins may help reduce risk - PBS
How new findings on ovarian cancer origins may help reduce risk PBS
UMBC Research Team Discovers Promising Molecular Target For Ovarian Cancer Treatment 2026 - UMBC - University Of Maryland, Baltimore County
UMBC Research Team Discovers Promising Molecular Target For Ovarian Cancer Treatment 2026 UMBC - University Of Maryland, Baltimore County
UAB clinical trial explores new approach to treat ovarian cancer - The University of Alabama at Birmingham
UAB clinical trial explores new approach to treat ovarian cancer The University of Alabama at Birmingham
ArriVent doses first patient in ARR-002 ovarian cancer trial By Investing.com - Investing.com India
ArriVent doses first patient in ARR-002 ovarian cancer trial By Investing.com Investing.com India
A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy - Nature
A tumor profiling resource for ovarian cancer: insights into chemotherapy-driven heterogeneity and personalized treatment strategy Nature
MSU Researchers Discover New Target to Overcome Ovarian Cancer Chemotherapy Resistance - MSUToday
MSU Researchers Discover New Target to Overcome Ovarian Cancer Chemotherapy Resistance MSUToday
How To Lower Ovarian Cancer Risk: Remove the Fallopian Tubes - Memorial Sloan Kettering Cancer Center
How To Lower Ovarian Cancer Risk: Remove the Fallopian Tubes Memorial Sloan Kettering Cancer Center
Rina-S Shows 45.9% Response Rate in Platinum-Resistant Ovarian Cancer - Cure Today
Rina-S Shows 45.9% Response Rate in Platinum-Resistant Ovarian Cancer Cure Today
OCRF and News Corp Australia Launch "Over It" Campaign to Close the Ovarian Cancer Survival Gap - Oncodaily
OCRF and News Corp Australia Launch "Over It" Campaign to Close the Ovarian Cancer Survival Gap Oncodaily
Jasmina Veta Darkovski: Insights From a Gynecologic Oncology Observership at Gemelli University Hospital - Oncodaily
Jasmina Veta Darkovski: Insights From a Gynecologic Oncology Observership at Gemelli University Hospital Oncodaily
Squamous Cell Carcinoma Arising in a Mature Cystic Teratoma of the Ovary: A Case Report - Cureus
Squamous Cell Carcinoma Arising in a Mature Cystic Teratoma of the Ovary: A Case Report Cureus
Functional profiling of ovarian cancer models reveals Bcl-xL/NOTCH targeting to overcome resistance - Nature
Functional profiling of ovarian cancer models reveals Bcl-xL/NOTCH targeting to overcome resistance Nature
A Giant Ovarian Mucinous Cystadenoma in an Adolescent Patient: A Case Report - Cureus
A Giant Ovarian Mucinous Cystadenoma in an Adolescent Patient: A Case Report Cureus
Lipids in ovarian cancer ascites impair T cell activation by disrupting TCR dynamics - Nature
Lipids in ovarian cancer ascites impair T cell activation by disrupting TCR dynamics Nature
Young adult ovarian cancer survivor: ‘Be aggressive when it comes to your health’ - UT MD Anderson
Young adult ovarian cancer survivor: ‘Be aggressive when it comes to your health’ UT MD Anderson
The Lancet Ovarian Cancer Commission Launches Global Survey to Inform Future Recommendations and Standards of Care - ESGO - Oncodaily
The Lancet Ovarian Cancer Commission Launches Global Survey to Inform Future Recommendations and Standards of Care - ESGO Oncodaily
ACOG Strengthens Ovarian Cancer Prevention Guidance - Medscape
ACOG Strengthens Ovarian Cancer Prevention Guidance Medscape
Diversity within ovarian cancer subtypes and their tumor microenvironment - Frontiers
Diversity within ovarian cancer subtypes and their tumor microenvironment Frontiers
ASCO Issues First Living Guideline for Recurrent Ovarian Cancer Treatment - CancerNetwork
ASCO Issues First Living Guideline for Recurrent Ovarian Cancer Treatment CancerNetwork
Fructose Contributes to Metastasis in Aggressive Ovarian Cancer - Inside Precision Medicine
Fructose Contributes to Metastasis in Aggressive Ovarian Cancer Inside Precision Medicine
Rethinking ovarian cancer III: the past decade and future directions - Nature
Rethinking ovarian cancer III: the past decade and future directions Nature
Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium | British Journal of Cancer - Nature
Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium | British Journal of Cancer Nature
Humana Medicaid may cover a test that checks tumor response to chemotherapy in gynecologic cancers. - Stock Titan
Humana Medicaid may cover a test that checks tumor response to chemotherapy in gynecologic cancers. Stock Titan
Emergency Hospital Admission Accounts for 40% of Ovarian Cancer Diagnoses in England - The ASCO Post
Emergency Hospital Admission Accounts for 40% of Ovarian Cancer Diagnoses in England The ASCO Post
Most ‘Ovarian Cancer’ Isn’t. And That Fact Can Save Lives. - The New York Times
Most ‘Ovarian Cancer’ Isn’t. And That Fact Can Save Lives. The New York Times
Does Ovarian Cancer Actually Originate in the Fallopian Tubes? - Lehigh Valley Health Network
Does Ovarian Cancer Actually Originate in the Fallopian Tubes? Lehigh Valley Health Network
ROSELLA Trial: New Ovarian Cancer Treatment Shows Survival Benefit - Oncology News Central
ROSELLA Trial: New Ovarian Cancer Treatment Shows Survival Benefit Oncology News Central
Bilateral salpingectomy – removal of the fallopian tubes – can reduce ovarian cancer risk by about 80% - UCLA Health
Bilateral salpingectomy – removal of the fallopian tubes – can reduce ovarian cancer risk by about 80% UCLA Health
FOLR1-targeted actinium-225–based alpha-particle therapy eliminates ovarian cancer - Science | AAAS
FOLR1-targeted actinium-225–based alpha-particle therapy eliminates ovarian cancer Science | AAAS
Integrating ultrasound-CT-MR for preoperative multi-task prediction in ovarian cancer: achieving diagnostic parity with multidisciplinary team consensus - Nature
Integrating ultrasound-CT-MR for preoperative multi-task prediction in ovarian cancer: achieving diagnostic parity with multidisciplinary team consensus Nature